head-and-neck-cancer

Documents about head-and-neck-cancer

• Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis#417521ClinicalTrials.gov
• Effect of a Multimodal Antiemetic Protocol on Postoperative Nausea and Vomiting in Patients Undergoing Flap Surgery for Head and Neck Cancer#890085ClinicalTrials.gov
• A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers#1008582ClinicalTrials.gov
• A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors#882679ClinicalTrials.gov
• TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy#314343ClinicalTrials.gov
• Activation of the cGAS-STING pathway contributes to cancer-related fatigue in a murine model of head and neck cancer#485117Europe PMC
• In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®#885217ClinicalTrials.gov
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors#849329ClinicalTrials.gov
• Effectiveness of RMSSD-Based Adaptive Music Therapy (Skitii) in Reducing Treatment-Related Anxiety in Head and Neck Cancer Patients: Protocol for a Randomized Controlled Trial#271996bioRxiv / medRxiv
• Toward a Better Paradigm for Head and Neck Cancer Treatment Applying AI (HNC-TACTIC): Protocol for an International Cohort Study of Electronic Health Records.#368116NCBI PubMed Central
• Supportive care needs among head and neck cancer patients in the recovery phase from 6 months to 2 years after treatment: which factors matter?#380926NCBI PubMed Central
• Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology#900878ClinicalTrials.gov
• An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy#852565ClinicalTrials.gov
• Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer#913690ClinicalTrials.gov
• Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial#873753ClinicalTrials.gov
• Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC#195323ClinicalTrials.gov
• Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease#321701ClinicalTrials.gov
• The development of a Patient Decision Aid and Patient Concerns Inventory for people diagnosed with recurrent head and neck cancer: a mixed-methods study protocol.#340296NCBI PubMed Central
• AI-assisted VMAT planning incorporating deep learning-based dose prediction for head and neck cancer: feasibility of quality standardization and human intervention for irregular cases.#409388NCBI PubMed Central
• Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors#1029817ClinicalTrials.gov
• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors#332761ClinicalTrials.gov
• Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression#837556ClinicalTrials.gov
• Monitoring Skeletal Muscle Mass Using CBCT in Patients With H&N Cancer Undergoing Chemoradiotherapy#880154ClinicalTrials.gov
• Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck#914280ClinicalTrials.gov
• The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors#847645ClinicalTrials.gov
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer#979196ClinicalTrials.gov
• Digital Phenotyping of Psychological Distress in Skin Cancer Patients#805545ClinicalTrials.gov
• Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors#824951ClinicalTrials.gov
• Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN#332739ClinicalTrials.gov
• Assessing the Patient Experience in Cancer Care#1032510ClinicalTrials.gov
• Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction#1045254ClinicalTrials.gov
• Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors#802430ClinicalTrials.gov
• A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation#1045159ClinicalTrials.gov
• Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors#882565ClinicalTrials.gov
• RAPA-201 Therapy of Solid Tumors#426773ClinicalTrials.gov
• RTX-224 Monotherapy in Patients With Solid Tumors#852137ClinicalTrials.gov
• A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck#855283ClinicalTrials.gov
• Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors#968773ClinicalTrials.gov
• A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers#853211ClinicalTrials.gov
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies#803666ClinicalTrials.gov
• Pharmacogenetic strategies to mitigate cisplatin-induced ototoxicity in head and neck cancer: A cost-minimization analysis with the use of <i>GSTP1</i> c.313A>G genotyping#120221PLOS
• A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours#870789ClinicalTrials.gov
• Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer#303731ClinicalTrials.gov
• Maximizing Quality of Life After Cancer Through Rehabilitation#860060ClinicalTrials.gov
• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)#238110ClinicalTrials.gov
• Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment#906458ClinicalTrials.gov
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy#1032715ClinicalTrials.gov
• S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx#844059ClinicalTrials.gov
• A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors#910994ClinicalTrials.gov
• Early Palliative Care For Patients With Oral Cancer in Sri Lanka#991754ClinicalTrials.gov